Rosiglitazone treatment restores renal responsiveness to atrial natriuretic peptide in rats with congestive heart failure

The thiazolidinedione (TZD) class of Peroxisome proliferator‐activated receptor gamma agonists has restricted clinical use for diabetes mellitus due to fluid retention and potential cardiovascular risks. These side effects are attributed in part to direct salt‐retaining effect of TZDs at the renal c...

Descripción completa

Detalles Bibliográficos
Autores principales: Goltsman, Ilia, Khoury, Emad E., Aronson, Doron, Nativ, Omri, Feuerstein, Giora Z., Winaver, Joseph, Abassi, Zaid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584517/
https://www.ncbi.nlm.nih.gov/pubmed/31087547
http://dx.doi.org/10.1111/jcmm.14366

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6584517/
https://www.ncbi.nlm.nih.gov/pubmed/31087547
http://dx.doi.org/10.1111/jcmm.14366

Ejemplares similares